Compare Jupiter (JUP) vs Enzyme (MLN) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Jupiter vs Enzyme — how do they compare? Jupiter trades at Rp2,985 (market cap Rp9,82T, Rp302,04M 24h volume), while Enzyme trades at Rp30,212 (market cap Rp134,13M, Rp104,56M 24h volume). The key difference: Jupiter is far larger — about 73212.6× Enzyme's market cap, and Jupiter's supply is capped (3,3B / 6,9B JUP (49%)) while Enzyme's keeps growing. Which is the better fit depends on your goals — on Pluang, investors hold Jupiter for 37 Days and Enzyme for 29 Days on average.
| JUP | MLN | |
|---|---|---|
Market Cap | Rp9,82T | Rp134,13M |
Volume (24h) | Rp302,04M | Rp104,56M |
Circulating Supply | 3,3B / 6,9B JUP (49%) | 3,3M MLN |
Typical Hold Time | 37 Days | 29 Days |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Jupiter (JUP) is trading at Rp3,063 with a market cap of Rp10.05 trillion, showing a bearish technical signal as moving averages indicate selling pressure. The asset has a circulating supply of 3.3 million out of 6.9 million tokens, with 49% in circulation and an average hold time of 37 days. Support and resistance levels suggest key price zones for monitoring.
Overall outlook is cautious due to bearish technicals and limited recent ecosystem updates. Opportunities include potential oversold conditions from RSI levels, while risks involve low liquidity and high volatility. Investors should watch for network activity changes and regulatory developments.
Enzyme (MLN) shows limited market activity with a modest market cap of Rp134,13M and circulating supply of 3,3jt tokens. The asset demonstrates relatively low volatility with an average hold time of 29 days, suggesting stable holder behavior. Trading volumes appear subdued across exchanges, indicating limited speculative interest. No significant protocol upgrades or ecosystem developments have been reported recently, though the project continues to operate its decentralized asset management platform.
Overall outlook remains cautious due to limited liquidity and trading activity. Key opportunities include potential ecosystem growth in decentralized finance asset management, while major risks include low market depth, regulatory uncertainty for DeFi protocols, and competition from larger DeFi platforms. The token's utility within its native protocol remains its primary value driver.
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Jupiter
As one of the industry's most advanced swap aggregation engines, Jupiter excels in delivering essential liquidity infrastructure for the Solana ecosystem. Moreover, Jupiter is actively expanding its DeFi product offerings, featuring a comprehensive suite that includes Limit Order, DCA/TWAP, Bridge Comparator, and Perpetuals Trading.
Read more on JUP →About Enzyme
Enzyme is an easy-to-use on-chain asset management system that enables access to digital assets and DeFi from one simple, unified app. It provides a front-to-back execution and order management system, which provides fully automated reporting, risk management, administration, governance and operations.
Read more on MLN →
